DAMGO, a μ‐opioid receptor selective ligand, distinguishes between μ‐and κ‐opioid receptors at a different region from that for the distinction between μ‐ and δ‐opioid receptors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Current protocols in molecular biology
1988 • 4,543 citations
Cloning of a Delta Opioid Receptor by Functional Expression
1992 • 1,225 citations
Chimeric α 2 -,β 2 -Adrenergic Receptors: Delineation of Domains Involved in Effector Coupling and Ligand Binding Specificity
1988 • 766 citations
Cloning and expression of a cDNA for the rat k‐opioid receptor
1993 • 234 citations
Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists
1989 • 232 citations
Multiple Morphine and Enkephalin Receptors and the Relief of Pain
1988 • 194 citations
Human kappa opiate receptor second extracellular loop elevates dynorphin's affinity for human mu/kappa chimeras
1994 • 99 citations
Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
1993 • 99 citations
Delineation of structural domains involved in the subtype specificity of tachykinin receptors through chimeric formation of substance P/substance K receptors.
1992 • 97 citations
Molecular cloning and in situ hybridization histochemistry for rat μ-opioid receptor
1994 • 95 citations
DAMGO, a μ‐opioid receptor selective agonist, distinguishes between μ‐ and δ‐opioid receptors around their first extracellular loops
1995 • 76 citations
Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
1992 • 34 citations
Identification of a region of the human endothelin ETA receptor required for interaction with bosentan
1994 • 12 citations